Related Experiment Video
Updated: Aug 22, 2025

Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy
Shonik Ganjoo1, Nahum Puebla-Osorio1, Selene Nanez1
1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Abstract:
The TGF-β superfamily is a group of secreted polypeptides with key roles in exerting and regulating a variety of physiologic effects, especially those related to cell signaling, growth, development, and differentiation. Although its central member, TGF-β, has been extensively reviewed, other members of the family-namely bone morphogenetic proteins (BMPs), activins, and growth and differentiation factors (GDFs)-have not been as thoroughly investigated. Moreover, although the specific roles of TGF-β signaling in cancer immunology and immunotherapy resistance have been extensively reported, little is known of the roles of BMPs, activins, and GDFs in these domains. This review focuses on how these superfamily members influence key immune cells in cancer progression and resistance to treatment.
Insights
The TGF-β superfamily, including BMPs, activins, and GDFs, impacts cancer progression and treatment resistance. This review explores their roles in immune cell function within the tumor microenvironment.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- The TGF-β superfamily regulates crucial physiological processes like cell signaling and differentiation.
- While TGF-β is well-studied, other members (BMPs, activins, GDFs) roles in cancer immunology are less understood.
- TGF-β signaling's impact on cancer immunology and immunotherapy resistance is documented, but knowledge gaps exist for related factors.
Purpose of the Study:
- To review the influence of BMPs, activins, and GDFs on immune cells.
- To elucidate the roles of these factors in cancer progression.
- To explore their involvement in resistance to cancer treatments.
Main Methods:
- Literature review of scientific articles.
- Analysis of studies focusing on TGF-β superfamily members beyond TGF-β.
- Synthesis of findings on immune cell modulation in cancer.
Main Results:
- BMPs, activins, and GDFs significantly affect immune cell behavior in the tumor microenvironment.
- These factors play roles in promoting or inhibiting cancer progression.
- Their influence on immunotherapy resistance mechanisms is increasingly recognized.
Conclusions:
- Understanding BMPs, activins, and GDFs is critical for advancing cancer immunology and therapy.
- Targeting these factors may offer novel strategies for overcoming treatment resistance.
- Further research is warranted to fully elucidate their complex roles in cancer immunity.
More Related Videos
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
Related Concept Videos
Tumor Immunotherapy
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Targeted Cancer Therapies
There are several types of targeted therapies against...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...